| A simple bioreactor-based method to generate kidney organoids from pluripotent stem cells A Przepiorski, V Sander, T Tran, JA Hollywood, B Sorrenson, JH Shih, ... Stem Cell Reports 11 (2), 470-484, 2018 | 223 | 2018 |
| HNF1β is essential for nephron segmentation during nephrogenesis RW Naylor, A Przepiorski, Q Ren, J Yu, AJ Davidson Journal of the American Society of Nephrology 24 (1), 77-87, 2013 | 94 | 2013 |
| Evaluation of cisplatin-induced injury in human kidney organoids JLM Digby, T Vanichapol, A Przepiorski, AJ Davidson, V Sander American Journal of Physiology-Renal Physiology 318 (4), F971-F978, 2020 | 77 | 2020 |
| Use of human induced pluripotent stem cells and kidney organoids to develop a cysteamine/mTOR inhibition combination therapy for cystinosis JA Hollywood, A Przepiorski, RF D’Souza, S Sreebhavan, EJ Wolvetang, ... Journal of the american society of nephrology 31 (5), 962-982, 2020 | 66 | 2020 |
| “Iron-saturated” bovine lactoferrin improves the chemotherapeutic effects of tamoxifen in the treatment of basal-like breast cancer in mice X Sun, R Jiang, A Przepiorski, S Reddy, KP Palmano, GW Krissansen BMC cancer 12, 1-12, 2012 | 54 | 2012 |
| Turning mesoderm into kidney AJ Davidson, P Lewis, A Przepiorski, V Sander Seminars in cell & developmental biology 91, 86-93, 2019 | 34 | 2019 |
| Influence of tail versus cardiac sampling on blood glucose and lipid profiles in mice YK Chan, PF Davis, SD Poppitt, X Sun, NS Greenhill, R Krishnamurthi, ... Laboratory animals 46 (2), 142-147, 2012 | 28 | 2012 |
| Modeling oxidative injury response in human kidney organoids A Przepiorski, T Vanichapol, EB Espiritu, AE Crunk, E Parasky, ... Stem Cell Research & Therapy 13 (1), 76, 2022 | 20 | 2022 |
| The Dynamics of Metabolic Characterization in iPSC-Derived Kidney Organoid Differentiation via a Comparative Omics Approach Q Wang, Y Xiong, S Zhang, Y Sui, C Yu, P Liu, H Li, W Guo, Y Gao, ... Frontiers in Genetics 12, 632810, 2021 | 20 | 2021 |
| Protocol for large-scale production of kidney organoids from human pluripotent stem cells V Sander, A Przepiorski, AE Crunk, NA Hukriede, TM Holm, AJ Davidson STAR protocols 1 (3), 100150, 2020 | 20 | 2020 |
| The utility of human kidney organoids in modeling kidney disease A Przepiorski, AE Crunk, EB Espiritu, NA Hukriede, AJ Davidson Seminars in nephrology 40 (2), 188-198, 2020 | 14 | 2020 |
| A simplified method for generating kidney organoids from human pluripotent stem cells A Przepiorski, AE Crunk, TM Holm, V Sander, AJ Davidson, NA Hukriede Journal of visualized experiments: JoVE, 2021 | 12 | 2021 |
| Derivation of induced pluripotent stem cell lines from New Zealand donors JK Oh, A Przepiorski, HH Chang, RC Dodd, V Sander, B Sorrenson, ... Journal of the Royal Society of New Zealand 52 (1), 54-67, 2022 | 10 | 2022 |
| Functional characterization of ion channels expressed in kidney organoids derived from human induced pluripotent stem cells N Montalbetti, AJ Przepiorski, S Shi, S Sheng, CJ Baty, JC Maggiore, ... American Journal of Physiology-Renal Physiology 323 (4), F479-F491, 2022 | 8 | 2022 |
| Validation of HDAC8 inhibitors as drug discovery starting points to treat acute kidney injury K Long, Z Vaughn, MD McDaniels, S Joyasawal, A Przepiorski, E Parasky, ... ACS Pharmacology & Translational Science 5 (4), 207-215, 2022 | 8 | 2022 |
| Genetically engineering endothelial niche in human kidney organoids enables multilineage maturation, vascularization and de novo cell types JC Maggiore, R LeGraw, A Przepiorski, J Velazquez, C Chaney, ... bioRxiv, 2023 | 3 | 2023 |
| A genetically inducible endothelial niche enables vascularization of human kidney organoids with multilineage maturation and emergence of renin expressing cells. JC Maggiore, R LeGraw, A Przepiorski, J Velazquez, C Chaney, ... Kidney International, 2024 | 1 | 2024 |
| Large-Scale Production of Kidney Organoids from Human Pluripotent Stem Cells V Sander, A Przepiorski, NA Hukriede, AJ Davidson Kidney Research: Experimental Protocols, 69-83, 2023 | 1 | 2023 |
| Modeling acute kidney injury in kidney organoids with cisplatin JLM Digby, A Przepiorski, AJ Davidson, V Sander bioRxiv, 2019.12. 22.886572, 2019 | 1 | 2019 |
| Use of human iPSCs and kidney organoids to develop a cysteamine/mTOR inhibition combination therapy to treat cystinosis JA Hollywood, A Przepiorski, PT Harrison, EJ Wolvetang, AJ Davidson, ... bioRxiv, 595264, 2019 | 1 | 2019 |
